A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry

(2012) Tao Zhang et al.   CLINICA CHIMICA ACTA

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

(2012) G. C. Prendergast et al.   CURRENT MEDICINAL CHEMISTRY

The Value of Diffusion-Weighted Magnetic Resonance Imaging in Assessing the Response of Locally Advanced Cervical Cancer to Neoadjuvant Chemotherapy

(2012) Chun Fu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling

(2012) Tao Zhang et al.   JOURNAL OF PROTEOME RESEARCH

Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study

(2012) Leonardo Tenori et al.   Molecular Oncology

Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer

(2012) Siwei Wei et al.   Molecular Oncology

Urine metabolite profiling offers potential early diagnosis of oral cancer

(2011) Guo X. Xie et al.   Metabolomics

Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy

(2008) Etienne Vincens et al.   CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Metabolomics-based methods for early disease diagnostics

(2008) GA Nagana Gowda et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer

(2008) Kidong Kim et al.   GYNECOLOGIC ONCOLOGY

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase

(2008) A. J. Muller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA